ISPRM/ESPRM guidelines on Physical and Rehabilitation Medicine professional practice for adults with obesity and related comorbidities

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
EDIZIONI MINERVA MEDICA
Autores
GIUSTI, Emanuele M.
SPATOLA, Chiara A.
BRUNANI, Amelia
KUMBHARE, Dinesh
ORAL, Aydan
ILIEVA, Elena
KIEKENS, Carlotte
PIETRABISSA, Giada
MANZONI, Gian Mauro
Citação
EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, v.56, n.4, p.496-507, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: The World Health Organization (WHO) has declared obesity as the largest global chronic health problem in adults. In the last years, attention has been drawn to rehabilitative interventions for patients with obesity. AIM: The aim of this manuscript is to provide Physical and Rehabilitation Medicine (PRM) physicians with evidence-based recommendations for the rehabilitation of patients with overweight or obesity and related comorbidities. DESIGN: Evidence-based guidelines. POPULATION : Adults with overweight or obesity. METHODS: Guidelines were based on GRADE and WHO recommendations. A comprehensive search of the available evidence about rehabilitation treatments for obesity was performed, and 17 separate systematic literature reviews were conducted. For each outcome, estimates of the effects of rehabilitation treatments were computed and employed along with an assessment of quality of evidence, desirable and undesirable effects, values and preferences to formulate the recommendations. Recommendations were reviewed by a consensus expert panel using a modified Delphi process. RESULTS : We strongly recommend providing comprehensive multiprofessional and multidisciplinary interventions including exercise, diet and behavioral or cognitive-behavioral therapy. The nutritional component of these treatments should include diets with either a high-protein or a low-fat content. It is strongly recommended to prescribe frequent moderate aerobic exercise. We strongly recommend providing cognitive-behavioral interventions as the behavioral component of rehabilitation programs. CONCLUSIONS: PRM physicians should lead multidisciplinary teams providing comprehensive and individualized rehabilitation programs for patients with overweight or obesity. These guidelines were endorsed by the International Society of Physical and Rehabilitation Medicine (ISPRM) and by the European Society of Physical and Rehabilitation Medicine (ESPRM).
Palavras-chave
Obesity, Overweight, Rehabilitation, Physical and Rehabilitation Medicine, Guidelines
Referências
  1. Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
  2. American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU
  3. Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013
  4. [Anonymous], 2007, CIRCULATION, V115, P2358
  5. Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415
  6. Berkowitz RI, 2011, PSYCHIAT CLIN N AM, V34, P747, DOI 10.1016/j.psc.2011.08.007
  7. Bray GA, 2018, ENDOCR REV, V39, P79, DOI 10.1210/er.2017-00253
  8. Brouwers MC, 2010, J CLIN EPIDEMIOL, V63, P1308, DOI 10.1016/j.jclinepi.2010.07.001
  9. Butryn ML, 2007, OBESITY, V15, P3091, DOI 10.1038/oby.2007.368
  10. Capodaglio P, 2014, EUR J PHYS REHAB MED, V50, P129
  11. Capodaglio P, 2019, EUR J PHYS REHAB MED, V55, P137, DOI 10.23736/S1973-9087.18.05393-5
  12. Capodaglio P, 2017, EUR J PHYS REHAB MED, V53, P611, DOI 10.23736/S1973-9087.17.04880-8
  13. Castelnuovo G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00559
  14. Cheng SH, 2018, CONSERV BIOL, V32, P762, DOI 10.1111/cobi.13117
  15. DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458
  16. Das SK, 2007, AM J CLIN NUTR, V85, P1023
  17. Dimitriou HT, 2007, NAT BUILT ENVIRON SE, P3
  18. Forhan M, 2013, BEST PRACT RES CL EN, V27, P129, DOI 10.1016/j.beem.2013.01.003
  19. Fortin MMR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-69
  20. Goh LY, 2013, J GASTROEN HEPATOL, V28, P54, DOI 10.1111/jgh.12293
  21. Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88
  22. Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI 10.1016/j.jclinepi.2011.06.004
  23. Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012
  24. Han TS, 1997, INT J OBESITY, V21, P127, DOI 10.1038/sj.ijo.0800377
  25. Harvey-Berino J, 2010, PREV MED, V51, P123, DOI 10.1016/j.ypmed.2010.04.018
  26. Hersey JC, 2012, PREV MED, V54, P42, DOI 10.1016/j.ypmed.2011.09.018
  27. Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009
  28. Higgins J, 2011, COCHRANE COLLAB, V5, P1, DOI 10.1002/9780470712184
  29. Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
  30. Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
  31. Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004
  32. Johnson WD, 2011, AM J MED, V124, P931, DOI 10.1016/j.amjmed.2011.04.033
  33. Kamper AL, 2017, ANNU REV NUTR, V37, P347, DOI 10.1146/annurev-nutr-071714-034426
  34. Kaplan LM, 2018, OBESITY, V26, P61, DOI 10.1002/oby.22054
  35. Kyle TK, 2016, ENDOCRIN METAB CLIN, V45, P511, DOI 10.1016/j.ecl.2016.04.004
  36. Lambers S, 2008, CLIN REHABIL, V22, P483, DOI 10.1177/0269215508084582
  37. Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5
  38. Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
  39. Mai K, 2018, METABOLISM, V83, P60, DOI 10.1016/j.metabol.2018.01.003
  40. Marckmann P, 2015, J RENAL NUTR, V25, P1, DOI 10.1053/j.jrn.2014.06.002
  41. Marques A, 2018, EUR J PUBLIC HEALTH, V28, P295, DOI 10.1093/eurpub/ckx143
  42. McMaster University, GRADEPRO GDT GRADEPR
  43. McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466
  44. Nurkkala M, 2015, EAT BEHAV, V18, P179, DOI 10.1016/j.eatbeh.2015.05.009
  45. Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
  46. Park S, 2017, QUAL LIFE RES, V26, P2209, DOI 10.1007/s11136-017-1565-x
  47. Radl KI, 2013, EPIDEMIOL BIOSTAT PU, V10, DOI 10.2427/8846
  48. Raggi A, 2010, DISABIL REHABIL, V32, P2028, DOI 10.3109/09638281003797372
  49. Ricca V, 2010, APPETITE, V55, P656, DOI 10.1016/j.appet.2010.09.019
  50. Rossner S, 1997, INT J OBESITY, V21, pS2
  51. Roy MC, 2018, NEW ZEAL MED J, V131, P100
  52. Ryan DH, 2017, CURR OBES REP, V6, P187, DOI 10.1007/s13679-017-0262-y
  53. Schwingshackl L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082853
  54. Seida JC, 2018, DISABIL REHABIL, V40, P125, DOI 10.1080/09638288.2016.1243163
  55. Shuger SL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-41
  56. Singh-Manoux A, 2014, OBESITY, V22, P1172, DOI 10.1002/oby.20651
  57. Succurro E, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002098
  58. Taylor RM, 2016, BMJ OPEN, V6
  59. Thomas DE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005105.pub2
  60. U.K. National Institute for Health and Care Excellence, 2014, OB ID ASS MAN CLIN G
  61. Uerlich MF, 2016, OBESITY FACTS, V9, P273, DOI 10.1159/000445192
  62. Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
  63. Wang YF, 2005, AM J CLIN NUTR, V81, P555
  64. WHO, 2014, WHO HDB GUID DEV
  65. Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415
  66. World Health Organization, 2020, OB OV
  67. Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
  68. Yancy WS, 2002, OBES RES, V10, P1057, DOI 10.1038/oby.2002.143
  69. Yanovski SZ, 2003, INT J EAT DISORDER, V34, pS117, DOI 10.1002/eat.10211
  70. Young MD, 2017, OBESITY, V25, P56, DOI 10.1002/oby.21696
  71. Yumuk V, 2015, OBESITY FACTS, V8, P402, DOI 10.1159/000442721